Page last updated: 2024-11-05

tolmetin and Bone Cancer

tolmetin has been researched along with Bone Cancer in 2 studies

Tolmetin: A non-steroidal anti-inflammatory agent (ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL) similar in mode of action to INDOMETHACIN.
tolmetin : A monocarboxylic acid that is (1-methylpyrrol-2-yl)acetic acid substituted at position 5 on the pyrrole ring by a 4-methylbenzoyl group. Used in the form of its sodium salt dihydrate as a nonselective nonsteroidal anti-inflammatory drug.

Research Excerpts

ExcerptRelevanceReference
" Ketorolac can be well tolerated in high-dose, long-term use even in this frail patient population."6.69The opioid-sparing effects of intravenous ketorolac as an adjuvant analgesic in cancer pain: application in bone metastases and the opioid bowel syndrome. ( Joishy, SK; Walsh, D, 1998)
" Ketorolac can be well tolerated in high-dose, long-term use even in this frail patient population."2.69The opioid-sparing effects of intravenous ketorolac as an adjuvant analgesic in cancer pain: application in bone metastases and the opioid bowel syndrome. ( Joishy, SK; Walsh, D, 1998)
" In addition, the total daily dose of ketorolac was reduced following a change from intermittent bolus dosing to a continuous infusion."1.30Prolonged central intravenous ketorolac continuous infusion in a cancer patient with intractable bone pain. ( Gordon, RL, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gordon, RL1
Joishy, SK1
Walsh, D1

Trials

1 trial available for tolmetin and Bone Cancer

ArticleYear
The opioid-sparing effects of intravenous ketorolac as an adjuvant analgesic in cancer pain: application in bone metastases and the opioid bowel syndrome.
    Journal of pain and symptom management, 1998, Volume: 16, Issue:5

    Topics: Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Bone Neoplasms; Colonic Ps

1998

Other Studies

1 other study available for tolmetin and Bone Cancer

ArticleYear
Prolonged central intravenous ketorolac continuous infusion in a cancer patient with intractable bone pain.
    The Annals of pharmacotherapy, 1998, Volume: 32, Issue:2

    Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Cathet

1998